AllisonO'NeillMD

Pediatric Hematology & Oncology • Boston, MA

Instructor, Dana-Farber Cancer Institute

Join to view full profile

Dr. O'Neill is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. O'Neill's full profile

Already have an account?

Office
450 Brookline Ave
Boston, MA 02215
Phone+1 617-632-4202
Is this information wrong?

Education & Training

Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2005 - 2008
Albert Einstein College of MedicineClass of 2005

Certifications & Licensure

MA State Medical License 2008 - 2025
FL State Medical License 2017 - 2019
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition Syndromes Start of enrollment: 2012 Mar 01
Active, not recruiting
Not Applicable
Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma Start of enrollment: 2020 Nov 01
Recruiting
Phase 2
ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma Start of enrollment: 2022 Jul 19
Recruiting
Phase 1, Phase 2

Publications & Presentations

PubMed

234 citations
The role of extracellular spacer regions in the optimal design of chimeric immune receptors: evaluation of four different scFvs and antigens.
Ryan D. Guest, Robert E. Hawkins, Natalia Kirillova, Eleanor J. Cheadle, Jennifer Arnold
Journal of Immunotherapy. 2005-05-01
41 citations
Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Sta...
Allison F. O'Neill, Alexander J. Towbin, Mark Krailo, Caihong Xia, Yun Gao
Journal of Clinical Oncology. 2017-09-11
125 citations
Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis.
Mandy L. Ballinger, Ana F. Best, Phuong L. Mai, Payal P. Khincha, Jennifer T. Loud
JAMA Oncology. 2017-12-01

Journal Articles

Screening with Whole-Body Magnetic Resonance Imaging in Pediatric Subjects with Li–Fraumeni Syndrome: A Single Institution Pilot Study
Judy E Garber, Lisa Diller, Junne Kamihara, Allison F O'Neill, Pediatric Blood & Cancer

Lectures

Alfa-feto protein (AFP) as a predictor of outcome for children with germ cell tumors: A report from the malignant germ cell international consortium.
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

Eureka Therapeutics Announces Initiation of Phase I/II ARYA-2 Clinical Trial of ET140203 ARTEMIS® T Cells to Treat Pediatric Liver CancerNovember 17th, 2021
Count Me in Launches New Project for Pediatric Hepatocellular Carcinoma (PediHCC) and HCC-like TumorsDecember 8th, 2023